The improvement of symptoms following use of a supplementary pulmonary vasodilator provides the hope that the chosen treatment could be a viable alternative approach for other similar cases. PubMed, Intern Med, 2015;54(21):2721–6. (Also see Treatments for Pulmonary Hypertension)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.